为何每天服用一片阿司匹林不再能让你远离医生…… - Suppr | 超能文献

Why an aspirin a day no longer keeps the doctor away ….

作者信息

Lordkipanidzé Marie

出版信息

Thromb Haemost. 2011 Feb;105(2):209-10. doi: 10.1160/TH10-11-0749. Epub 2010 Dec 6.

DOI:10.1160/TH10-11-0749

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Why an aspirin a day no longer keeps the doctor away ….为何每天服用一片阿司匹林不再能让你远离医生……

Thromb Haemost. 2011 Feb;105(2):209-10. doi: 10.1160/TH10-11-0749. Epub 2010 Dec 6.

2

24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.稳定性冠心病患者的 24 小时时间依赖性阿司匹林疗效。

Thromb Haemost. 2011 Feb;105(2):336-44. doi: 10.1160/TH10-02-0082. Epub 2010 Dec 7.

3

Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.阿司匹林停药后的血小板功能恢复：志愿者和手术患者的初步研究。

Eur J Anaesthesiol. 2010 Jul;27(7):617-23. doi: 10.1097/EJA.0b013e328335b354.

4

Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocythemia.每日两次服用阿司匹林以提高原发性血小板增多症患者体内阿司匹林的生物学疗效。

Thromb Res. 2012 Jan;129(1):91-4. doi: 10.1016/j.thromres.2011.09.017. Epub 2011 Oct 19.

5

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.比较六种主要血小板功能测试以确定稳定型冠状动脉疾病患者中阿司匹林抵抗的发生率。

Eur Heart J. 2007 Jul;28(14):1702-8. doi: 10.1093/eurheartj/ehm226. Epub 2007 Jun 14.

6

How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.如何优化氯吡格雷治疗？通过血小板聚集试验指导治疗调整来降低低反应发生率。

Thromb Haemost. 2008 Feb;99(2):357-62. doi: 10.1160/TH07-10-0624.

7

Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.阿司匹林抵抗个体的血小板敏感性增加——对亚最大浓度花生四烯酸的血小板聚集可预测抗血小板治疗反应。

Thromb Haemost. 2008 Jul;100(1):83-9. doi: 10.1160/TH07-10-0590.

8

The aspirin resistance controversy: clinical entity or platelet heterogeneity?阿司匹林抵抗争议：临床实体还是血小板异质性？

Circulation. 2006 Jun 27;113(25):2865-7. doi: 10.1161/CIRCULATIONAHA.106.635847.

9

Aspirin resistance in patients with coronary artery disease - which test to use in routine management?冠心病患者的阿司匹林抵抗——在常规管理中应使用哪种检测方法？

Blood Coagul Fibrinolysis. 2008 Jun;19(4):324-6. doi: 10.1097/MBC.0b013e3282fa1a1f.

10

Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.通过VerifyNow阿司匹林系统和光透射聚集法评估阿司匹林反应。

Thromb Res. 2008;123(2):267-73. doi: 10.1016/j.thromres.2008.03.023. Epub 2008 May 21.

引用本文的文献

1

Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis.高血栓风险患者每日一次与每日两次阿司匹林治疗的比较：系统评价与荟萃分析。

Am J Cardiovasc Drugs. 2021 Jan;21(1):63-71. doi: 10.1007/s40256-020-00409-x.

2

Effectiveness of antiplatelet therapy in atherosclerotic disease: comparing the ASA low-response prevalence in CVD, CAD and PAD.抗血小板治疗在动脉粥样硬化疾病中的疗效：比较 CVD、CAD 和 PAD 中 ASA 低反应率的患病率。

J Thromb Thrombolysis. 2014;37(2):190-201. doi: 10.1007/s11239-013-0919-7.